Role of gpr30 in testicular germ cell tumors: A potential new anticancer target

Cancer Biology and Therapy

Volumn 11, Issue 8, 2011, Pages 773-775

  Vitale, Giovanni ^a,b   Dicitore, Alessandra ^b   Sciortino, Giovanna ^a,b   Abbruzzese, Alberto ^c   Persani, Luca ^a,b   Santini, Daniele ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR 30;

CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; GERM CELL TUMOR; HUMAN; METASTASIS; NONHUMAN; NOTE; PROTEIN EXPRESSION;

ANIMALS; HUMANS; MALE; MOLECULAR TARGETED THERAPY; NEOPLASMS, GERM CELL AND EMBRYONAL; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS;

EID: 79954569824     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.8.15272     Document Type: Note

References (34)

1. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007; 87:905-31; PMID: 17615392. (Pubitemid 47084672)
2. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, Strissel PL. Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 2009; 66:2405-26; PMID: 19333551.
3. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146:624-32; PMID: 15539556. (Pubitemid 40129818)
4. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625-30; PMID: 15705806. (Pubitemid 40354745)
5. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204:105-14; PMID: 19767412.
6. Filardo EJ, Thomas P. GPR30: a seven-transmembrane- spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005; 16:362-7; PMID: 16125968. (Pubitemid 41338741)
7. Prossnitz ER, Arterburn JB, Smith HO, Opream TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008; 70:165-90; PMID:18271749. (Pubitemid 351738176)
8. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, et al. The G protein-coupled receptor GPR30 mediates c-fos upregulation by 17betaestradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004; 279:27008-16; PMID: 15090535. (Pubitemid 38812536)
9. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30 and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000; 14:1649-60; PMID: 11043579.
10. Sanden C, Broselid S, Cornmark L, Andersson K, Daszkiewicz-Nilsson J, Martensson U, et al. G protein- coupled estrogen receptor 1 (GPER1)/GPR30 localizes in the plasma membrane and trafficks intracellularly on cytokeratin intermediate filaments. Mol Pharmacol 2011; 79:400-10. PMID: 21149639.
11. Filardo EJ, Quinn JA, Sabo E. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 2008; 73:870-3; PMID: 18289622.
12. Wang D, Hu L, Zhang G, Zhang L, Chen C. G protein-coupled receptor 30 in tumor development. Endocrine 2010; 38:29-37; PMID: 20960099.
13. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol 2009; 36:524-31; PMID: 19995644.
14. Owman C, Blay P, Nilsson C, Lolait SJ. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun 1996; 228:285-92; PMID: 8920907. (Pubitemid 26396067)
15. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67:1859-66; PMID: 17308128. (Pubitemid 46383413)
16. Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, et al. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 2010; 70:1184-94; PMID:20086172.
17. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 2009; 28:523 32; PMID: 19153601.
18. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, et al. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 2006; 12:6359-66; PMID: 17085646 (Pubitemid 44799705)
19. Kleuser B, Malek D, Gust R, Pertz HH, Potteck H. 17-Beta-estradiol inhibits transforming growth factor- beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol Pharmacol 2008; 74:1533-43; PMID: 18768737.
20. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, et al. 17beta-estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006; 70:1414-23; PMID: 16835357. (Pubitemid 44435994)
21. He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 2009; 100:1051-61; PMID: 19432902.
22. Jordan VC. SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst 2007 99:350-6; PMID: 17341726. (Pubitemid 47078725)
23. Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007; 196:3861-9; PMID:17403429.
24. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, et al. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 2009; 114:465-71; PMID: 19501895.
25. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 2005; 5:210-22; PMID: 15738984. (Pubitemid 40314952)
26. Chieffi P, Franco R, Portella G. Molecular and cell biology of testicular tumors. Int Rev Cell Mol Biol 2009; 278:277-308; PMID: 19815181.
27. Pais V, Leav I, Lau KM, Jiang Z, Ho SM. Estrogen receptor-β expression in human testicular germ cell tumors. Clin Cancer Res 2003; 9:4475-82; PMID: 14555521. (Pubitemid 37248406)
28. Hirvonen-Santti SJ, Rannikko A, Santti H, Savolainen S, Nyberg M, Janne OA, et al. Downregulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer. Eur Urol 2003; 44:74; PMID:14644130.
29. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004; 22:2-14; PMID: 15034740. (Pubitemid 41406567)
30. Franco R, Boscia F, Gigantino V, Marra L, Esposito F, Ferrara D, et al. GPR30 is overexpressed in post puberal testicular germ cell tumors. Cancer Biol Ther 2011; 15:609-13. PMID: 21278491.
31. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006; 2:207-12; PMID: 16520733.
32. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, et al. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008; 116:1648-55; PMID: 19079715.
33. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO. The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle. J Vasc Res 2011; 48:327-35; PMID:21273787.
34. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol 2009; 5:421-7; PMID: 19430488.